approval · primary record
EPINEPHRINE
FDA · NDA · 2025-03-13
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-03-13 |
| Brand | EPINEPHRINE |
| Sponsor | FRESENIUS KABI USA |
| Route | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:17.605Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:EPINEPHRINE:2025-03-13
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.